The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Petrayevskiy A.V.

Volgograd State Medical University

Trishkin K.S.

Volgograd State Medical University;
Volgograd Regional Clinical Hospital No. 1

Gndoyan I.A.

Volgograd State Medical University

Lomakina V.E.

Volgograd State Medical University;
Volgograd Regional Clinical Hospital No. 1

Adelshina N.A.

Volgograd State Medical University;
Volgograd Regional Clinical Hospital No. 1

Idiopathic intracranial hypertension (case study)

Authors:

Petrayevskiy A.V., Trishkin K.S., Gndoyan I.A., Lomakina V.E., Adelshina N.A.

More about the authors

Journal: Russian Annals of Ophthalmology. 2021;137(5): 122‑129

Read: 2973 times


To cite this article:

Petrayevskiy AV, Trishkin KS, Gndoyan IA, Lomakina VE, Adelshina NA. Idiopathic intracranial hypertension (case study). Russian Annals of Ophthalmology. 2021;137(5):122‑129. (In Russ.)
https://doi.org/10.17116/oftalma2021137051122

Recommended articles:
Non-invasive auto­mated methods for the diagnosis of periorbital skin tumors. Russian Annals of Ophthalmology. 2024;(5):137-145
Features of como­rbidity pathology in young people. Russian Journal of Preventive Medi­cine. 2024;(11):63-69
Modern view on the etiology of gallstone disease in children. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):59-68
Application of modern methods for acti­vation of brain functions in obese patients (literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):54-61

References:

  1. Markey KA, Mollan SP, Jensen RH, Sinclair AJ. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 2016;15:78-91.  https://doi.org/10.1016/S1474-4422(15)00298-7
  2. Nikiforov AS, Guseva MR. Neyrooftal’mologiya. Rukovodstvo [Neuroophthalmology: A guide]. M.: GEOTAR-Media; 2008. (In Russ.).
  3. Hoffmann J, Kreutz KM, Csapó-Schmidt C, Becker N, Kunte H, Fekonja LS, Jadan A, Wiener E. The effect of CSF drain on the optic nerve in idiopathic intracranial hypertension. J Headache Pain. 2019;20:59.  https://doi.org/10.1186/s10194-019-1004-1
  4. Egorova ES. Risk factors for the optic nerve secondary atrophy development in patients with idiopathic intracranial hypertension. Vestnik VGMU = Bulletin of VGMU. 2016;15(3):78-83 (In Russ.).
  5. Magzhanov RV, Davletova AI, Bahtiyarova KZ, Pervushina EV, Tunik VF. Benign intracranial hypertension: clinical observations. Annaly Klinicheskoj I Experimental’noj Nevrologii = Annals of Clinical and Experimental Neurology. 2017;11(3):53-59. (In Russ.). https://doi.org/10.18454/ACEN.2017.3.8
  6. Bjerre P. The empty sella. A reappraisal of etiology and pathogenesis. Acta Neurol Scand. 1990;130:1-25. 
  7. Bettie AM, Trope GE. Glaucomatous optic neuropathy and field loss in primary empty sella syndrome. Can J Ophtalmol. 1991;26(7):377-382. 
  8. Jaja-Albarran A, Bayort J, De Juan M, Benito C. Spontaneous partial empty sella: A study of 41 cases. Exp Clin Endocrinol. 1984;83(1):63-72.  https://doi.org/10.1055/s-0029-1210313
  9. Likhachev SA, Astapenko AV, Pleshko IV, Korbut TV, Antonenko AI, Naumenko DV, Gvishch TG, Merkul OV. Idiopathic intracranial hypertension (IIH). Nevrologiya i nejrohirurgiya. Vostochnaya Evropa = Neurology and Neurosurgery. Eastern Europe. 2015;2(26):145 (In Russ.).
  10. Astakhov YuS, Stepanova EE, Bikmullin VN. Benign intracranial hypertension (pseudotumor cerebri). Klinicheskaya oftal’mologiya = Clinical Ophthalmology. 2001;1:8-12 (In Russ.).
  11. Miller NR, Newman NJ. The essentials: Walsh & Hoyt’s clinical neuro-ophthalmology, 5th edition. Baltimore: Williams & Wilkins; 1999;820. 
  12. Frisen L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry. 1982;45(1):13-18.  https://doi.org/10.1136/jnnp.45.1.13
  13. Golenkov AK. The value of spontaneous pulse of retinal veins in the diagnosis of intracranial hypertension. Oftal’mologicheskij zhurnal = Ophthalmological Journal. 1982;5(253):265-267 (In Russ.).
  14. Miljic D, Pekic S., Popovic V. Empty Sella. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000 [ https://www.ncbi.nlm.nih.gov/books/NBK532084
  15. Neyrokhirurgiya. Evropeyskoye rukovodstvo [Neurosurgery. European guide]. In 2 volumes. Eds Lumenta C.B., et al. M.: Panfilov publisher; BINOM; Laboratoria znaniy; 2013;1:392. (In Russ.).
  16. Parkhomenko EV, Nartov SE, Barinov AN, Karpov DYu, Sorokina EA. The problem of diagnosis and treatment of idiopathic intracranial hypertension. Medicinskij alfavit = Medical alphabet. 2017;2(15):5-13 (In Russ.).
  17. Subramaniam S, Fletcher WA. Obesity and Weight Loss in Idiopathic Intracranial Hypertension: A Narrative Review. J Neuroophthalmol. 2017;37(2): 197-205.  https://doi.org/10.1097/WNO.0000000000000448
  18. Pizova NV. Idiopathic intracranial hypertension and the place of acetazolamide in treatment. Consilium Medicum. Nevrologiya i revmatologiya (Pril.) = Consilium Medicum. Neurology and rheumatology (App.). 2016;1:60-64 (In Russ.).
  19. Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL. Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Invest Ophthalmol Vis Sci. 2016;57(3):805-812.  https://doi.org/10.1167/iovs.15-18626.
  20. Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116(5):322-327.  https://doi.org/10.1111/j.1600-0404.2007.00905.x
  21. Thurtell MJ, Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management. Curr Treat Options Neurol. 2013;15(1):1-12.  https://doi.org/10.1007/s11940-012-0207-4
  22. Chatziralli I, Theodossiadis P, Theodossiadis G, Asproudis I. Perspectives on diagnosis and management of adult idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol. 2018;256(7):1217-1224. https://doi.org/10.1007/s00417-018-3970-4
  23. Kalyvas AV, Hughes M, Koutsarnakis C, Moris D, Liakos F, Sakas DE, Stranjalis G, Fouyas I. Efficacy, complications and cost of surgical interventions for idiopathic intracranial hypertension: a systematic review of the literature. Acta Neurochir (Wien). 2017;159(1):33-49.  https://doi.org/10.1007/s00701-016-3010-2
  24. Daggubati LC, Liu KC. Intracranial venous sinus stenting: a review of idiopathic intracranial hypertension and expanding indications. Cureus. 2019; 11(2):e4008. https://doi.org/10.7759/cureus.4008
  25. Spitze A, Lam P, Al-Zubidi N, Yalamanchili S, Lee AG. Controversies: Optic nerve sheath fenestration versus shunt placement for the treatment of idiopathic intracranial hypertension. Indian J Ophthalmol. 2014;62(10): 1015-1021. https://doi.org/10.4103/0301-4738.146012
  26. Albrecht P, Blasberg C, Ringelstein M, Müller AK, Finis D, Guthoff R, Kadas EM, Lagreze W, Aktas O, Hartung HP, Paul F, Brandt AU, Methner A. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension. J Neurol. 2017;264(7):1370-1380. https://doi.org/10.1007/s00415-017-8532-x
  27. Goldhagen BE, Bhatti MT, Srinivasan PP, Chiu SJ, Farsiu S, El-Dairi MA. Retinal Atrophy in Eyes With Resolved Papilledema Detected by Optical Coherence Tomography. J Neuroophthalmol. 2015;35(2):122-126.  https://doi.org/10.1097/WNO.0000000000000210

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.